Arkolith/Insider Trading/ROIV/Form 4

Epperly Melissa B,

DirectorRoivant Sciences Ltd. (ROIV) · full profile →Form 4 · filed Jul 1, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$610K
Net Open-Market Flow
-$610K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 29, 2026Option exercise(M)18K$4.46$79K34K
Jun 29, 2026Sell(S)15K$34.32$515K19K
Jun 29, 2026Sell(S)3K$34.71$95K16K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 29, 2026Option exercise(M)18K—$0169K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001807359-26-000010) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Roivant Sciences Ltd.

Build

Ask your agent about ROIV insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001807359-26-000010"
Ask your agent
Use Arkolith to summarize insider buying and selling at Roivant Sciences Ltd.
over the last 90 days and cite the filings.